Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.
Department of Clinical Sciences, Danderyd Hospital & Department of Surgery, Ersta Hospital, Karolinska Institutet, 116 91, Stockholm, Sweden.
Obes Surg. 2020 Mar;30(3):1086-1092. doi: 10.1007/s11695-019-04304-6.
BACKGROUND/OBJECTIVE: Body mass index (BMI) is central when evaluating treatment effect after gastric bypass. The metabolic impact of BMI-independent differences in body fat percentage (BF%) after gastric bypass is not fully understood. We compared metabolic and adipose tissue characteristics in women with high versus low BF% independent of BMI after obesity remission following gastric bypass.
SUBJECTS/METHODS: A cohort of 215 women was included at baseline. A total of 166 women were re-examined 2 years after gastric bypass, whereof 130 had obesity remission (BMI < 30 kg/m). Anthropometric parameters, blood pressure, and lipids were measured. Total and regional body fat mass was determined by dual-energy X-ray absorptiometry. Insulin sensitivity was assessed by homeostasis model assessment of insulin resistance (HOMA-IR) and hyperinsulinemic euglycemic clamp (M value). Adipocyte size and number were determined.
Of the 130 women with obesity remission, 64 had BF% ≥ 35 and 65 < 35. Independent of BMI, high BF% were associated with higher HOMA-IR (P = 0.021), lower M value (P = 0.0046), higher triglycerides (P = 0.013), higher visceral/total and android/gynoid fat mass ratios (P = 0.0032 and 0.0003 respectively), and larger subcutaneous fat cell volume (P < 0.0001) 2 years after gastric bypass. No differences in anthropometric measures, glucose, blood pressure, or fat cell number were observed.
Independent of BMI, patients with higher BF% displayed lower insulin sensitivity, higher triglyceride levels, central fat distribution, and larger subcutaneous adipocytes 2 years after gastric bypass. Thus, determination of BF% provides additional information of metabolic characteristics at follow-up of non-obese patients after gastric bypass.
背景/目的:体重指数(BMI)是评估胃旁路术后治疗效果的核心指标。然而,胃旁路术后 BMI 以外的体脂百分比(BF%)的变化对代谢的影响尚未完全阐明。本研究旨在比较肥胖缓解后胃旁路术后 2 年,BMI 独立的高 BF%与低 BF%患者的代谢和脂肪组织特征。
本研究纳入了 215 名基线患者。其中,166 名患者在肥胖缓解(BMI<30kg/m)后 2 年进行了复查。通过双能 X 射线吸收法测量人体成分,评估了总脂肪量和各部位脂肪量。通过稳态模型评估的胰岛素抵抗指数(HOMA-IR)和高胰岛素正葡萄糖钳夹试验(M 值)评估胰岛素敏感性。通过测定脂肪细胞大小和数量评估脂肪组织。
在肥胖缓解的 130 名患者中,64 名患者的 BF%≥35%,65 名患者的 BF%<35%。无论 BMI 如何,高 BF%患者的 HOMA-IR 更高(P=0.021),M 值更低(P=0.0046),甘油三酯水平更高(P=0.013),内脏/总脂肪和腹型/女性型脂肪比率更高(P=0.0032 和 0.0003),皮下脂肪细胞体积更大(P<0.0001)。此外,我们还发现两组患者的体重、腰围、臀围、血压和脂肪细胞数量均无显著差异。
胃旁路术后 2 年,与 BMI 独立的高 BF%患者相比,低 BF%患者的胰岛素敏感性更低,甘油三酯水平更高,中心性肥胖更为明显,且皮下脂肪细胞体积更大。因此,BF%的测定可提供肥胖缓解患者胃旁路术后随访时的代谢特征信息。